Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s737, 2026. DOI: 10.25251/0y59xj91. Disponível em: https://skin.dermsquared.com/skin/article/view/4059. Acesso em: 29 apr. 2026.